11630 SW 97 Street, Miami, Florida 33176, US

Advertising Driven Press Release Distribution

Tag: Drug

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis

Press Release
Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.” The report features an extensive study of the current market landscape, offering an informed. Read More>>

Growing at an annualized rate of 10%, the fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, claims Roots Analysis

Press Release
Traditional drug discovery is associated with exorbitant investments, prolonged lead evolution timelines and high attrition rates; the fragment-based approach is a versatile technique, enabling researchers to mitigate a number of existing challenges  London Roots Analysis has announced the addition of the “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030” report to its list of offerings. According to experts in this field, fragment-based drug discovery solutions have facilitated the identification. Read More>>

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis

Press Release
 With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis has announced the addition of “In Vitro ADME Testing Services Market, 2019-2030” report to its list of offerings. According to the US Food and Drug Administration (USFDA), less than 10% of investigational new. Read More>>

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis

Press Release
With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis has announced the addition of “In Vitro ADME Testing Services Market, 2019-2030” report to its list of offerings. According to the US Food and Drug Administration (USFDA), less than 10% of investigational new. Read More>>

Test Helps Identify Newborn’s Exposed to the Gabapentin Abuse

Press Release
Gabapentin Testing Available in Umbilical Cord Tissue Des Plaines, IL., April 2, 2020—Over the last few decades, United States Drug Testing Laboratories, Inc. (USDTL), has been quietly making a huge impact on the lives of some of the most vulnerable Neonatal Intensive Care Unit (NICU) patients, newborns exposed to substances of abuse during gestation. Today USDTL announced that they are adding gabapentin detection to their long list of drugs that. Read More>>

Subscribe to Our Newsletter

For exclusive content regarding the latest trends in the world of Press Release distribution.